Navigating Medications: A Targeted Approach to POTS
At a Glance
While no medications are FDA-approved specifically for POTS, doctors use off-label drugs like beta-blockers, fludrocortisone, and ivabradine to target specific symptoms. These medications act as a bridge to stabilize your heart rate, enabling you to engage in lifestyle and exercise therapies.
While there are currently no medications specifically FDA-approved to treat POTS, doctors frequently use existing medicines “off-label” to manage symptoms [1][2]. These medications act as a “pharmacological bridge”—they stabilize your heart rate and blood pressure so that you can feel well enough to participate in the essential lifestyle and exercise protocols that lead to long-term recovery [3][4].
A Targeted Approach to Medication
Because POTS is a diverse condition, the choice of medication often depends on your specific biological “glitches” or subtype [4][2].
For High Adrenaline (Hyperadrenergic)
If your body overproduces stress hormones like norepinephrine when you stand, the goal is to block those “fight-or-flight” signals [5][2].
- Beta-Blockers (e.g., Propranolol, Metoprolol): These work by blocking adrenaline from binding to receptors in your heart. This slows your heart rate and can reduce the “wired” or shaky feeling many patients experience [4][2].
- Warning: Beta-blockers can lower blood pressure, which may be dangerous for POTS patients who already struggle with low blood pressure. They may also exacerbate fatigue or asthma in some patients [4][6].
For Low Blood Volume (Hypovolemic)
If your body doesn’t have enough circulating blood, medications can help you “hold on” to the fluids you drink [7][8].
- Fludrocortisone: This is a synthetic hormone that signals your kidneys to retain sodium and water. This expands your total blood volume, providing a larger “reservoir” of fluid to support your blood pressure when you stand [4][9].
- Warning: Fludrocortisone frequently depletes potassium in the body. If you are on this medication, you will likely need routine bloodwork to monitor your levels and may require a potassium supplement [4].
For Blood Pooling (Neuropathic)
If the nerves that tell your blood vessels to “squeeze” are damaged, medications can manually tighten those vessels [10][4].
- Midodrine: This medication stimulates receptors in your blood vessels to make them constrict (narrow). This increases peripheral resistance, which helps push blood back up from your legs toward your heart and brain [4][6].
- Warning (Supine Hypertension): Midodrine can cause dangerously high blood pressure if you lie completely flat while it is active in your system. Patients must not lie down flat for at least 3 to 4 hours after taking a dose [4][6].
The Unique Role of Ivabradine
Ivabradine has become a significant option for POTS patients, especially those who struggle with low blood pressure or severe fatigue from beta-blockers [7][11].
Unlike beta-blockers, which can lower blood pressure and affect the whole body, ivabradine is highly selective. It works by slowing the “funny current” in the heart’s natural pacemaker (the sinoatrial node) [7]. This allows it to lower your heart rate without dropping your blood pressure or making you feel as tired as traditional heart medications might [7][11].
Medication Matching Guide
Doctors often mix and match these treatments based on your symptoms:
| Medication | Main Action | Best For… |
|---|---|---|
| Beta-Blockers | Blocks adrenaline | Racing heart, tremors, high adrenaline [4] |
| Ivabradine | Slows heart pacemaker | High heart rate with low blood pressure [7] |
| Fludrocortisone | Increases blood volume | Low blood volume, lightheadedness [4] |
| Midodrine | Tightens blood vessels | Blood pooling in legs, fainting [4] |
| Pyridostigmine | Boosts nerve signals | Increasing “rest and digest” (parasympathetic) tone [4] |
Important Safety Note: Because these medications are used off-label, they require close supervision by a specialist. Never stop or change your dosage without medical guidance, as some medications need to be tapered slowly to avoid a “rebound” of symptoms [4][2].
Common questions in this guide
Are there any FDA-approved medications for POTS?
How do beta-blockers help treat POTS?
Why is fludrocortisone prescribed for POTS?
What is the supine hypertension warning for midodrine?
Why might a doctor prescribe ivabradine instead of a beta-blocker for POTS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my POTS subtype, which of these off-label medications do you think is the best starting point for me?
- 2.If we decide on a beta-blocker, should we start with a low dose of a non-selective one like propranolol or a cardioselective one like metoprolol?
- 3.Since my blood pressure tends to be on the lower side, is ivabradine a safer option for me to lower my heart rate?
- 4.How often should I monitor my blood pressure at home if we start fludrocortisone or midodrine?
- 5.Can we use these medications as a 'bridge' to help me feel stable enough to begin the CHOP or Levine exercise protocol?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of randomized trials.
Kwok CS, Lee S, Hall M, et al.
Trends in cardiovascular medicine 2025; (35(8)):517-527 doi:10.1016/j.tcm.2025.07.001.
PMID: 40653179 - 2
Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review.
Ghazal M, Akkawi AR, Fancher A, et al.
Current problems in cardiology 2025; (50(3)):102977 doi:10.1016/j.cpcardiol.2024.102977.
PMID: 39706392 - 3
Adaptive Approaches to Exercise Rehabilitation for Postural Tachycardia Syndrome and Related Autonomic Disorders.
Ziaks L, Johnson K, Schiltz K, et al.
Archives of rehabilitation research and clinical translation 2024; (6(4)):100366 doi:10.1016/j.arrct.2024.100366.
PMID: 39822199 - 4
Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
Mar PL, Raj SR
Annual review of medicine 2020; (71()):235-248 doi:10.1146/annurev-med-041818-011630.
PMID: 31412221 - 5
Carbidopa: beyond Parkinson's disease.
Lenka A, Vernino S
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2025; (35(3)):347-352 doi:10.1007/s10286-025-01122-y.
PMID: 40056295 - 6
Postural orthostatic tachycardia syndrome (POTS) occurring during treatment for breast cancer.
Babra D, Youn S, Devendra S
BMJ case reports 2021; (14(8)) doi:10.1136/bcr-2021-242472.
PMID: 34353826 - 7
Use of Ivabradine in the Treatment of Patients with Postural Orthostatic Tachycardia Syndrome (POTS): A Systematic Review.
Melo APG, Moretti MA, Chagas ACP
Arquivos brasileiros de cardiologia 2025; (122(11)):e20250347 doi:10.36660/abc.20250347.
PMID: 41538594 - 8
Pathophysiological mechanisms of Postural Orthostatic Tachycardia Syndrome analyzed by means of hemodynamics.
Wei L, Cheng H, Chen S, et al.
PloS one 2025; (20(7)):e0327236 doi:10.1371/journal.pone.0327236.
PMID: 40601666 - 9
Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome.
Williams EL, Raj SR, Schondorf R, et al.
Autonomic neuroscience : basic & clinical 2022; (237()):102906 doi:10.1016/j.autneu.2021.102906.
PMID: 34823150 - 10
Management of Post-Viral Postural Orthostatic Tachycardia Syndrome With Craniosacral Therapy.
Tafler L, Chaudry A, Cho H, Garcia A
Cureus 2023; (15(2)):e35009 doi:10.7759/cureus.35009.
PMID: 36938206 - 11
Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
Gee ME, Watkins AK, Brown JN, Young EJA
American journal of cardiovascular drugs : drugs, devices, and other interventions 2018; (18(3)):195-204 doi:10.1007/s40256-017-0252-1.
PMID: 29330767
This page provides educational information about off-label medications for POTS. Always consult your specialist before starting, stopping, or changing the dosage of any medication.
Get notified when new evidence is published on Postural Orthostatic Tachycardia Syndrome (POTS).
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.